Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India-Reference-Cited by-同舟云学术

Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India

Published:2020-07-20 Issue:9 Volume:21 Page:578-587
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Dravid A¹²³^ORCID,Betha TP²,Sharma AK²,Gawali R²,Mahajan U⁴,Kulkarni M¹,Saraf C⁵,Kore S⁶,Dravid M⁷,Rathod N⁸

Affiliation:

1. Department of Medicine Ruby Hall Clinic Pune Maharashtra India

2. Department of Medicine Poona Hospital and Research Centre Pune Maharashtra India

3. Department of Medicine Noble Hospital Pune Maharashtra India

4. Department of Biostatistics VMK Diagnostics Private Limited Pune Maharashtra India

5. Department of Pathology VMK Diagnostics Private Limited Pune Maharashtra India

6. Department of Dermatology Ashwini Sahakari Rugnalaya and Research Centre Solapur Maharashtra India

7. Infectious Disease Clinic Dhule Maharashtra India

8. Department of Medicine Apex Hospital Kolhapur Maharashtra India

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.12912

Reference47 articles.

1. HIV estimates through 2018

2. WHO | Data and statistics. Available at:http://www.who.int/hiv/data/en/. Accessed on: 13 Nov 2019.

3. HIV and AIDS in Asia & the Pacific regional overview Avert. 2015. Available at:https://www.avert.org/professionals/hiv‐around‐world/asia‐pacific/overview. Accessed on: 13 Nov 2019 .

4. HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials

5. Country comparison: HIV/AIDS ‐ people living with HIV/AIDS — the world factbook ‐ central intelligence agency. Available at:https://www.cia.gov/library/publications/resources/the‐world‐factbook/fields/364rank.html. Accessed on13 Nov 2019.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial;Medicine;2023-11-03

2. Revisiting efavirenz in the era of dolutegravir: Low-dose efavirenz, a viable alternative capable of holding its own against dolutegravir-based regimens;Current Medicine Research and Practice;2023

3. Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial;Medicine;2022-12-02